Investors pushed First Advantage shares up 5.8% to $20.68 on Monday, anticipating the company’s official move into the S&P SmallCap 600 index. This latest rally extends the stock’s performance to a 42% gain so far this year, signaling strong market confidence ahead of Tuesday’s trading session.
Shares of Northern Oil and Gas surged 6.3% to $19.68 in Monday trading, defying a recent 28% three-month slump. The market reacted sharply after the company boosted its stock repurchase authorization to $243 million, signaling confidence despite broader volatility in the energy sector.
A $225 million injection from the U.S. Department of Commerce is set to accelerate Bosch’s $2 billion overhaul of its Roseville facility. The funding bolsters a broader strategy to shift silicon carbide semiconductor production onto American soil, marking a significant pivot in the company's domestic manufacturing footprint.
A sharp reversal in artificial intelligence stocks pushed the Nasdaq composite lower today, fueled by a record 15% plunge in SK Hynix shares. The downturn marks a cooling period for the year's primary market engine, as investors grow increasingly skeptical about the sustainability of the recent AI-driven rally.
President Trump’s decision to reimpose a blockade on Iranian shipping sent energy markets into a sharp rally Monday, shattering hopes for a quick resolution to escalating tensions in the Middle East. The move follows a series of direct military strikes and the closure of the critical Strait of Hormuz.
A 6.8% surge in Genius Sports shares on Monday signaled renewed investor confidence following the company’s role in a new three-way partnership. By bridging Polymarket’s prediction platform with Mexico's premier professional soccer league, the company aims to monetize its official data streams in a volatile market environment.
As major lenders prepare to report second-quarter results this week, the industry faces a paradox: solid current revenues are being overshadowed by investor anxiety regarding long-term sustainability. While economic indicators remain robust, the market is pivoting from short-term credit concerns toward the durability of net interest income growth.
Investors pushed Oncolytics Biotech shares up 16% to $1.03 on Monday morning following the company's announcement of a critical FDA meeting scheduled for August. The discussion will center on integrating a registrational component into the ongoing study targeting RAS-mutant, microsatellite-stable metastatic colorectal cancer.
A 27% surge in Braiin shares followed the company’s debut of ARIA, an agentic automation platform tailored for global real estate. Despite this intraday climb to $7, the stock remains down 52% year-to-date, marking a volatile period for the AI platform provider as it pivots toward specialized industry software.
Two oil-and-gas producers have signed on to utilize Enterprise Group’s mobile natural gas-to-electricity systems, marking a strategic expansion for the company across Western Canada. This shift toward localized power generation reflects a broader move by energy firms to electrify operations using cleaner, on-site fuel sources.
A single intravenous dose of VY1706 reduced tau protein levels by up to 75% in non-human primates over six months, according to new toxicology data. Following these results, Voyager Therapeutics intends to move its investigational gene therapy into human clinical trials for early-stage Alzheimer’s disease later this year.
With shares climbing 23% over the past year, Richemont prepares to reveal its fiscal first-quarter performance this Wednesday. Analysts project the Swiss luxury conglomerate will report sales reaching 5.89 billion euros, a notable rise from the 5.41 billion euros recorded during the same period in the previous fiscal year.
Gadi Levin has stepped into the role of chief financial officer at A2Z Cust2Mate Solutions, the company announced Monday. He takes the helm from Alan Rootenberg, who will maintain his presence on the board of directors for the Nasdaq-listed retail technology firm.
A potential strike at Air Canada has been averted after the carrier reached a four-year tentative agreement with the International Association of Machinists and Aerospace Workers. The deal covers roughly 11,000 employees across technical operations, airport services, cargo, and logistics, providing a framework for labor stability through March 2030.
The U.S. Food and Drug Administration has officially accepted Bristol Myers Squibb’s application for mezigdomide, a potential new treatment for relapsed or refractory multiple myeloma. The regulatory body set a target action date of May 13, 2027, marking a significant milestone for the Princeton-based pharmaceutical firm.
Shares of Q32 Bio rocketed 81% to $20.25 in premarket trading after the clinical-stage biotechnology firm reported that its experimental drug, bempikibart, delivered a significant reduction in hair loss for patients suffering from alopecia.
India’s merchandise trade deficit surged to $30.43 billion in June, a sharp departure from the $19.10 billion recorded during the same period last year. The widening gap, reported Monday by the commerce and industry ministry, reflects a cooling in both import and export activity as the nation navigates complex trade negotiations.
With daily production hitting 16,921 barrels of oil equivalent, Condor Energies is steadily expanding its footprint in Uzbekistan. The Canadian firm’s latest surge follows the successful integration of the Kumli-42 vertical well into its existing infrastructure, marking a significant step up from the 15,283 barrels recorded just weeks ago.
Demand for data center infrastructure is positioning ABB to outperform as the Swiss industrial giant prepares to report second-quarter results this Thursday. Analysts anticipate a significant climb in profitability, with consensus estimates pointing toward $1.88 billion in operational earnings, a marked increase from the $1.60 billion recorded last year.
The insatiable global hunger for artificial intelligence hardware is pushing ASML Holding toward another guidance hike, as the Dutch semiconductor giant prepares to report its second-quarter earnings on Wednesday. Analysts anticipate the company will capitalize on a market where demand for advanced chipmaking equipment consistently outstrips existing supply.
Agenus is betting its future on a late-stage colon cancer treatment, securing up to $340 million through a private equity placement. The Lexington-based immuno-oncology firm plans to shift its clinical focus, prioritizing a new phase 3 trial while cutting funding for existing metastatic cancer research.
A 14% drop in share price greeted investors this morning as Plus500 reported a sharp contraction in new customer acquisitions. The online trading platform’s stock hit 4,254 pence in early European trading, marking a retreat from previous bullish outlooks regarding the company's performance trajectory for the remainder of the year.
As Ericsson prepares to release its second-quarter earnings on Tuesday, analysts anticipate a sharper decline in both profit and sales compared to last year. The Swedish telecom giant faces a shifting market landscape where slowing 5G infrastructure investments in the United States currently overshadow growth potential in Europe and India.
A sharp rise in oil and natural gas prices dominated early trading sessions, pushing Brent crude up 3.8% to $78.89 a barrel. While energy markets reacted to supply shifts, broader equity indices struggled to maintain momentum, reflecting investor caution across both U.S. futures and major European exchanges ahead of the market open.
A sharp escalation in hostilities between Washington and Tehran sent crude prices soaring Monday, as the Strait of Hormuz—a vital artery for one-fifth of global energy supplies—became the focal point of fresh military strikes and tanker attacks, triggering a wave of risk-off sentiment across Asian equity markets.
Umenohana Co. Ltd. posted a net profit of 253 million yen for the fiscal year ending April 30, reversing a 383 million yen loss recorded in the previous period. The shift into the black follows a steady rise in annual revenue to 29.82 billion yen, up from 29.44 billion yen a year earlier.
Kurotani Corp. has reported a significant financial turnaround for the nine-month period ending May 31, posting a net profit of 2.28 billion yen. This marks a sharp recovery from the 388 million yen loss recorded during the same period last year, driven by a substantial increase in overall group revenue.
A 29 percent drop in net profit marks a challenging start to the fiscal year for Studio Alice Co. Ltd., as the Japanese photography chain reported 111 million yen in earnings for the first quarter ending May 31, down from the 157 million yen recorded during the same period last year.
176 million yen in net profit for the first quarter ending May 31 marks a decline for Daiwa Co. Ltd., sliding from the 189 million yen recorded during the same period last year. Despite the bottom-line contraction, the company managed to expand its operating profit against a backdrop of slightly lower total revenue.
Curves Holdings Co. Ltd. posted a net profit of 3.82 billion yen for the nine-month period ending May 31, representing a notable increase from the 3.23 billion yen recorded during the same timeframe last year. The results, filed under Japanese accounting standards, reflect steady gains across the company's financial metrics.
